TIAR and TIA-1 mRNA binding proteins co-aggregate under conditions of rapid oxygen decline and extreme hypoxia, suppress HIF-1alpha pathway and inhibit proliferation and angiogenesis by Gottschald, Oana Raluca
  
TIAR and TIA-1 mRNA binding proteins co-aggregate under 
conditions of rapid oxygen decline and extreme hypoxia, 
suppress HIF-1α pathway and inhibit proliferation and 
angiogenesis  
 
 
 
 
 
 
 
Inaugural Dissertation 
submitted to the 
Faculty of Medicine  
in partial fulfillment of the requirements 
for the PhD-Degree 
of the Faculties of Veterinary Medicine and Medicine 
of the Justus Liebig University Giessen 
by 
Oana Raluca Gottschald 
born in 
Bucharest, Romania 
 
 
 
 
 
 
 
Giessen 2010 
  
 
 
 
 
 
 
2 
 
 
 
 
 
 
From the Department of Internal Medicine II 
Director: Prof. Dr. W. Seeger 
of the Faculty of Medicine of the Justus Liebig University Giessen 
 
 
 
 
 
 
First Supervisor and Committee Member:  PD Dr. Jörg Hänze 
Second Supervisor and Committee Member:  Prof. Dr. Stefan Hüttelmaier 
Committee Members:    Prof. Dr. Heinz-Jürgen Thiel 
          Prof. Dr. Lienhard Schmitz 
 
 
 
 
 
 
Date of oral Defense:  
19.01.2011 
 
 
 
  
 
 
 
 
 
 
3 
 
 
 
I. Table of Contents 
 
I. Table of Contents.................................................................................... 3 
II. List of Figures ......................................................................................... 6 
III. Abbreviations....................................................................................... 8 
1 Introduction ........................................................................................... 11 
1.1 Hypoxia and gene regulation by HIF-1........................................... 11 
1.2 Hypoxia and regulation of translation............................................. 13 
1.2.1 Regulation of general translation ............................................ 14 
1.2.2 TIAR and TIA-1 mRNA binding proteins ................................. 15 
2 Aims of the Study.................................................................................. 18 
3 Materials and Methods.......................................................................... 19 
3.1 Cell Culture .................................................................................... 19 
3.1.1 Culture of the human lung adenocarcinoma A549 cell line..... 19 
3.1.2 Culture of human umbilical vein endothelial cells (HUVEC) ... 20 
3.2 Hypoxia experiments ..................................................................... 21 
3.2.1 Hypoxia inducing methods...................................................... 21 
3.2.2 Validating hypoxia within the cells using HypoxiprobeTM-1 ..... 21 
3.3 Immunocyto- and immunohisto-fluorescent analyses .................... 22 
3.3.1 Antibodies............................................................................... 22 
3.3.2 Immunostaining protocol......................................................... 23 
3.4 Western-blot analysis..................................................................... 23 
3.4.1 Samples preparation............................................................... 23 
3.4.2 BCA protein concentration assay............................................ 24 
3.4.3 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)......... 25 
3.4.4 Electro blotting of immobilized proteins .................................. 26 
3.4.5 Immunological detection of immobilized proteins ................... 27 
3.5 Small interfering RNA .................................................................... 29 
  
 
 
 
 
 
 
4 
3.6 Transfection of A549 and HUVEC cells ......................................... 30 
3.7 Reporter gene assay...................................................................... 31 
3.7.1 Recombinant plasmids ........................................................... 31 
3.7.2 Experiment design and measurement of the Luciferase activity
 32 
3.8 Cell count assay ............................................................................ 33 
3.9 BrdU incorporation assay............................................................... 33 
3.10 Tube formation assay .................................................................... 34 
4 Results .................................................................................................. 38 
4.1 Formation of TIAR/TIA-1 containing stress granules under different 
stress conditions in A549 cells.................................................................. 38 
4.2 Analyses of different hypoxic conditions employed for culturing of 
A549 cells ................................................................................................. 40 
4.3 Formation of TIAR/TIA-1 containing stress granules under different 
conditions of hypoxia in A549 cells........................................................... 42 
4.4 Immunocyto-fluorescent analysis of HIF-1α, c-Myc and lamin B in 
relation to TIAR and the nuclear stain DAPI in A549 cells cultured in 
hypoxia. .................................................................................................... 44 
4.5 Inhibition of TIAR and TIA-1 by siRNA (si-TIAR, si-TIA-1) in relation 
to a random siRNA (si-con) in A549 cells ................................................. 46 
4.6 Effects of TIAR and TIA-1 on HIF-1α............................................. 48 
4.6.1 HRE reporter gene assay ....................................................... 51 
4.6.2 AUR reporter gene assay ....................................................... 52 
4.7 HIF-1α and TIA-1 distribution in A549 tumor xenografts................ 54 
4.8 Effects of TIAR and TIA-1 on proliferation ..................................... 56 
4.9 Formation of TIAR/TIA-1 containing stress granules under different 
conditions of hypoxia in HUVEC cells....................................................... 58 
4.10 Inhibition of TIAR and TIA-1 by siRNA in HUVEC cells ................. 60 
4.11 Effects si-TIAR and si-TIA-1 on angiogenesis in endothelial cells . 61 
5 Discussion............................................................................................. 63 
6 Summary............................................................................................... 67 
  
 
 
 
 
 
 
5 
7 Zusammenfassung ............................................................................... 68 
8 References............................................................................................ 70 
9 Appendix ............................................................................................... 80 
9.1 Acknowledgments.......................................................................... 80 
9.2 CV.................................................................................................. 81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
6 
 
 
 
 
II.  List of Figures 
 
Figure 1. Hypoxic regulation of the hypoxia-inducible factor-1α (HIF-1α) .... 13 
Figure 2. Transcriptional and posttranscriptional regulation under hypoxic 
stress conditions. ......................................................................................... 14 
Figure 3. Translational initiation in the absence or presence of stress......... 16 
Figure 4. Formation of TIAR/TIA-1 containing stress granules under different 
stress conditions in A549 cells. .................................................................... 39 
Figure 5. Measurement of the oxygen partial pressure equilibration time in 
the cell supernatant...................................................................................... 41 
Figure 6. Validation of hypoxia in A549 cells cultured under different hypoxic 
conditions. .................................................................................................... 42 
Figure 7. Formation of TIAR/TIA-1 containing stress granules under different 
conditions of hypoxia in A549 cells. ............................................................. 43 
Figure 8. Immunocyto-fluorescent analysis of HIF-1α, c-Myc and lamin B in 
relation to TIAR and the nuclear stain DAPI in A549 cells cultured in hypoxia.
..................................................................................................................... 45 
Figure 9. Inhibition of TIAR and TIA-1 by siRNA (si-TIAR, si-TIA-1) in relation 
to a random siRNA (si-con) in A549 cells..................................................... 47 
Figure 10. Effects of the treatment of A549 cells by si-TIAR or si-TIA-1 
compared to si-con on the expression of HIF-1α analysed by Western-blot.48 
Figure 11. Effects of the treatment of A549 cells by si-TIAR or si-TIA-1 
compared to si-con on the expression of HIF-1α, analysed by 
immunocytologic-fluorescence. .................................................................... 50 
Figure 12. HRE-reporter gene analyse of A549 cells treated by si-TIAR or si-
TIA-1 compared to si-con............................................................................. 52 
Figure 13. AUR-reporter gene analyse of A549 cells treated by si-TIAR or si-
TIA-1 compared to si-con............................................................................. 53 
  
 
 
 
 
 
 
7 
Figure 14. Immunohistologic-fluorescent analysis of HIF-1α (green), TIA-1 
(red) and the merged version (HIF-1α + TIA-1) in sections from A549 tumor 
xenografts in relation to DAPI staining. ........................................................ 55 
Figure 16. Formation of TIAR/TIA-1 containing stress granules under 
different conditions of hypoxia in HUVEC cells. ........................................... 59 
Figure 17. Inhibition of TIAR and TIA-1 by siRNA (si-TIAR, si-TIA-1) in 
relation to a random siRNA (si-con) in HUVEC cells as measured by 
Western-blot................................................................................................. 60 
Figure 18. Effects of the treatment of HUVEC cells by si-TIAR or si-TIA-1 
compared to si-con on angiogenesis as measured by tube formation assay.
..................................................................................................................... 61 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
8 
III. Abbreviations 
 
AMPK adenosine monophosphate kinase 
ARNT aryl hydrocarbon nuclear translocator 
ATCC American Type Culture Collection 
ATF6 activating transcription factor 6 
ATP adenosine triphosphate 
AUR AU-rich 
bHLH basic helix-loop-helix 
BSA  bovine serum albumin 
CBP cAMP response element binding protein 
CMV cytomegalovirus 
DAPI 4’, 6’- diamidino-2-phenylindole 
DMEM Dulbecco's modified eagle medium 
DMSO  dimethylsulfoxide 
DNA deoxyribonucleic acid 
EDTA ethylenediaminetetraacetic acid 
eIF eukaryotic initiation factor 
ER endoplasmic reticulum 
FIH-1 factor inhibiting HIF-1 
GCN2 serine/threonine-protein kinase GCN2 
GDP guanosine diphosphate 
GTP guanosine triphosphate 
HBSS  Hank’s buffered salt solution 
  
 
 
 
 
 
 
9 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HRE hypoxia-responsive element 
HRI heme regulated inhibitor 
HRP  Horseradish peroxidase 
HUSAR Heidelberg Unix Sequence Analysis resources 
HUVEC human umbilical vein endothelial cells 
IRE1 endoplasmic reticulum-to-nucleus signaling 1 
MAPK Mitogen-activated protein kinase 
MCS multiple cloning site 
NF-κB nuclear factor 'kappa-light-chain-enhancer' of activated B-
cells 
NTPs nucleoside triphosphate 
P300 E1A binding protein p300 
P53 protein 53 
PCR polymerase chain reaction 
PERK pancreatic endoplasmic reticulum eIF2alpha kinase 
PHD2 prolyl hydroxylase domain protein 2 
PKR protein kinase R 
POP6 performance-optimized polymer 6 
Pro proline 
RACK1 receptor for activated C-kinase 
RNA ribonucleic acid 
ROS reactive oxygen species 
RT room temperature 
  
 
 
 
 
 
 
10 
SDS sodium dodecyl sulfate 
siRNA small interfering ribonucleic acid 
TIA-1 T-cell intracellular antigen 1 
TIAR TIA-1 related protein 
TK thymidine kinase 
Tris tris(hydroxymethyl)aminomethane 
TSR template suppression reagent 
UV ultraviolet 
VEGF vascular endothelial growth factor 
VHL von Hippel–Lindau tumor suppressor protein 
BCA bicinchoninic acid 
PVDF polyvinylidene fluoride 
ECL enhanced chemi-luminescence 
BrdU 5-bromo-2’-deoxyuridine 
HBSS Hank's Buffered Salt Solution 
 
 
 
 
 
 
 
 
 
 
 Introduction 
 
 
 
 
 
 
11 
1 Introduction 
 
 
Cellular hypoxia occurs under physiologic conditions during development (1, 
2), physical activity (3) and exposure to hypoxic environment (4, 5). Hypoxia 
is also caused by various pathophysiological conditions. Among them are 
pulmonary (6), cardiac and vascular diseases (7), inflammation (8, 9), 
transplantation (10) and cancer (11, 12).  
Hypoxia induces cellular adaptation processes at the level of transcription 
and translation. These adaptive responses often depend on the degree of 
hypoxia (13, 14).  
 
1.1 Hypoxia and gene regulation by HIF-1 
 
Hypoxia stabilizes and transactivates the transcription factor HIF-1, that 
initiates a wide gene expression program to handle the hypoxic situation (for 
review see (15)). In particular, HIF-1 induces target genes that attenuate 
mitochondrial respiration and induces glycolytic ATP generation. 
Furthermore, HIF-1 increases oxygen transfer and induces angiogenesis a 
multilayer process that requires proliferation and migration of endothelial 
cells. HIF-1 is involved in this process since it induces several genes 
encoding pro-angiogenic factors and components (16). The most prominent 
factor represents the vascular endothelial growth factor (VEGF) and its 
proangiogenic receptor VEGF-R2 (17-19).  
Also, HIF-1 causes a cell cycle arrest by targeting cyclin-dependent kinase 
inhibitors thus inhibiting proliferation (20). These effects favor cell survival 
and increase the resistant of cells towards hypoxia. On the other hand, HIF-1 
induces apoptosis by induction of various pro-apoptotic proteins (21-23). 
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HIF-1 consists of an O2-regulated HIF-1α and a constitutively expressed HIF-
1β subunit (24). In well-oxygenated cells, HIF-1α is hydroxylated at proline 
residue 402 (Pro-402) and/or Pro-564 by prolyl hydroxylase domain protein 2 
(PHD2), which uses O2 and α-ketoglutarate as substrates in a reaction that 
generates CO2 and succinate as byproducts (15). Prolylhydroxylated HIF-1α 
is bound by the von Hippel–Lindau tumor suppressor protein (VHL), which 
recruits an E3-ubiquitin ligase that targets HIF-1α for proteasomal 
degradation (Figure 1). Asparagine 803 in the transactivation domain is 
hydroxylated in well-oxygenated cells by factor inhibiting HIF-1 (FIH-1), which 
blocks the binding of the coactivators p300 and CBP (25, 26). Under hypoxic 
conditions, the prolyl and asparaginyl hydroxylation reactions are inhibited by 
substrate (O2) deprivation and/or the mitochondrial generation of reactive 
oxygen species (ROS), which may oxidize Fe(II) present in the catalytic 
center of the hydroxylases (27). Stabilized HIF-1α interacts with the 
constitutively expressed HIF-1β (aryl hydrocarbon nuclear translocator; 
ARNT). The HIF-1 complex then translocates to the nucleus and activates 
genes with hypoxia-responsive elements in their promoters (28). 
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Figure 1. Hypoxic regulation of the hypoxia-inducible factor-1α (HIF-1α) 
Regulation of the hypoxia-inducible factor-1α (HIF-1α) occurs primarily through 
inhibition of its degradation in hypoxia. Under normoxic conditions, HIF-1α 
undergoes rapid proteosomal degradation once it forms a complex with von Hippel–
Landau tumor suppressor factor (VHL) and E3 ligase complex. This requires the 
hydroxylation of critical proline residues by a family of HIF-1α-specific prolyl 
hydroxylases (PHD-1,2,3), which requires O2 and several cofactors, including iron. 
Under hypoxic conditions, or when iron is chelated or competitively inhibited, proline 
hydroxylation does not occur, thus stabilizing HIF-1α and allowing it to interact with 
the constitutively expressed HIF-1β (aryl hydrocarbon nuclear translocator; ARNT). 
The HIF-1 complex then translocates to the nucleus and activates genes with 
hypoxia-responsive elements in their promoters. bHLH, basic helix-loop-helix; CBP, 
cAMP response element binding protein; FIH, factor inhibiting HIF-1α; PAS, PER-
ARNT-SIM; TAD, transactivation domain.(28) 
 
 
1.2 Hypoxia and regulation of translation 
 
Regulation of translation is an important aspect of controlling gene 
expression at a superior level, allowing cells to rapidly respond to varying 
intracellular and extracellular stress, such as hypoxia (29-32) thus interfering 
with HIF-dependent gene regulation. This is affected by mechanisms 
targeting the general translation efficiency. Also, the fate of specific mRNAs 
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is targeted by various mRNA binding proteins affecting mRNA decay (33, 
34), mRNA stability (35, 36), mRNA splicing (37) and mRNA translation (38).  
Transcriptional
regulation
Hypoxia inducible
factor-1 (HIF-1)
Target genes 
involved in:
• oxygen transfer
• angiogenesis
• metabolism
• proliferation
• cell-cycle
• apoptosis
Postranscriptional regulation
Proteins 
promoting
mRNA 
decay
(AUF1)
Proteins 
promoting
mRNA 
stabilization / 
modulation of 
translation
(Hu proteins)
Proteins 
silencing
translation 
(TIAR, TIA-1)
Hypoxic stress conditions
Global 
initiation of 
translation:
eIF2-PERK-
controlled
pathway
General translation Specific translation
 
Figure 2. Transcriptional and posttranscriptional regulation under hypoxic 
stress conditions. 
Hypoxic stress conditions affect regulation at the transcriptional by induction of HIF-
1a that initiates a wide gene expression program to handle the hypoxic situation. Its 
target genes are involved in various processes among them are oxygen transfer, 
angiogenesis, metabolism, proliferation, cell-cycle and apoptosis. Induction of genes 
is also controlled at the posttranscriptional level. These mechanisms include 
modulation of general translation by the eIF2-PERK controlled pathway and also 
translation of specific mRNAs. This is mediated by proteins promoting mRNA decay 
like AUF1 (33, 34), by proteins promoting mRNA stabilization like Hu proteins (35, 
36) and by proteins that silence the translation (general translation or translation of 
specific targets) like TIAR and TIA-1 (39, 40). 
 
 
1.2.1 Regulation of general translation  
 
Global translation is regulated by the initiation of translation, which depends 
on the action of the eukaryotic initiation factor (eIF) family members (41, 42). 
A key regulatory process that targets translation is the activity of the 
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endoplasmic reticulum (ER) kinase (PERK) which can be phosphorylated in 
response to activation of the ER stress pathway under hypoxic conditions. In 
turn, PERK phosphorylates eIF2α and blocks global initiation of translation 
(43). Other pathways can also be initiated in response to hypoxia, for 
example by activation of adenosine monophosphate kinase (AMPK), 
phosphoinositide 3-kinase, or by the ER transmembrane proteins IRE1 and 
ATF6, which interfere with translational control (30, 44-46). 
 
1.2.2 TIAR and TIA-1 mRNA binding proteins  
 
The mRNA binding proteins T-cell intracellular antigen 1 (TIA-1) and TIA-1 
related protein (TIAR) affect mainly the stabilization, splicing and access for 
translation of mRNAs. TIAR/TIA-1 proteins can aggregate to visible stress 
granules under stress conditions in a reversible manner. Stress granules 
represent a kind of activated stage of these proteins assembled with 
additional components in distinct aggregates both stabilizing and silencing 
certain mRNAs. TIA proteins are important for determining the fate of 
mRNAs, including the regulation of splicing, stability, storage, and translation 
efficiency (39, 47-51).  
The TIAR/TIA-1 proteins can selectively target specific mRNAs by binding to 
specific adenosine-uridine rich (AUR) elements located at the 3′ end of the 
target mRNAs (39, 40, 52-54).  
The TIA-proteins are characterized by three RNA-binding domains and a 
glutamine-rich carboxyl-terminal domain that enable aggregation to insoluble 
aggregates.  
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Figure 3. Translational initiation in the absence or presence of stress. 
(Green panels) In the absence of stress, eIF2B promotes the charging of the eIF2-
GTP-tRNAMet ternary complex by exchanging GDP for GTP. When the eIF2-GTP-
tRNAMet ternary complex is available, a canonical 48S preinitiation complex is 
assembled at the 5' end of capped transcripts (green arrow: Normal) and scanning 
begins. Upon recognition of the initiation codon by the anticodon of tRNAMet, eIF5 
promotes GTP hydrolysis, and early initiation factors are displaced by the 60S 
ribosomal subunit. As additional ribosomes are added to the transcript, the mRNA is 
converted into a polysome. (Red panels) In stressed cells (red arrow: Stress), 
phosphorylation of eIF2α by PKR, PERK, HRI or GCN2 converts eIF2 into a 
competitive antagonist of eIF2B, depleting the stores of eIF2/GTP/tRNAMet. Under 
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these conditions, TIA-1 is included in a non-canonical, eIF2/eIF5-deficient 48S* 
preinitiation complex (composed of all components of the 48S pre-initiation complex 
except eIF2 and eIF5) that is translationally silent. TIA-1 self-aggregation then 
promotes the accumulation of these complexes at discrete cytoplasmic foci known 
as stress granules. Blue square, eIF5; green triangle, eIF2 bound to GTP; yellow 
triangle, eIF2 bound to GDP; red triangle, phospho-eIF2 bound to GDP.(55) 
 
 
Formation of stress granules has been demonstrated to display anti-apoptotic 
effects favoring cell survival under certain conditions. In this regard, the 
scaffold protein RACK1 was revealed as a crucial mediator. However, the 
anti-apoptotic effects related to stress granule formation can differ between 
certain conditions and may depend on the severity of the stress stimuli (56).  
In this context it is of note, that TIAR/TIA-1 proteins were demonstrated to 
exhibit a pro-apoptotic role in thymocytes. This was suggested to be 
mediated by its effects on translation and differential splicing of certain target-
mRNAs. However, in this study, the formation of stress granules by certain 
stress stimuli was not induced (57).  
Targeted disruption of TIAR or TIA-1 result in embryonic lethality. 
Interestingly, the penetrance of lethality depends on the mice strains and is 
higher for TIAR than for TIA-1. Embryonic lethality is suggested to be related 
to the requirement of TIAR/TIA-1 for cell viability (58, 59).  
Hypoxia has been suggested as a trigger for TIAR/TIA-1-dependent stress 
granule aggregation in different studies and organisms (31, 60, 61). Also, 
stress granules have been suggested to contribute to the development of 
therapy-resistant cancer cells (62, 63), in particular in hypoxic tumor areas 
(64, 65). 
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2 Aims of the Study  
 
 
Hypoxia represents a condition of cellular stress that causes adaptation 
processes at different cellular levels such as the regulation of transcription 
and translation.  
Hypoxia-dependent control of transcription is mainly dependent on the 
transcription factor HIF-1 that is specifically induced in hypoxia.  
Hypoxia-dependent control of translation is mediated by different 
mechanisms involving regulatory components of the general translational 
machinery. Also, mRNA binding proteins such as TIAR/TIA-1 contribute by 
affecting the availability of specific mRNAs for translation. TIAR/TIA-1 
proteins can aggregate to visible stress granules under stress conditions in a 
reversible manner representing an activated form of these proteins. 
Hypoxia is a dynamic stress condition that strongly can vary in its severity 
with regard to the cellular responses. These responses can cause changes in 
cellular function with impact on proliferation and angiogenesis. 
In this context, this work addressed the following questions:  
 
1)  Does hypoxia affect the formation of TIAR/TIA-1 containing stress 
granules in A549 cells and is the severity of hypoxia (absolute oxygen 
concentration and the kinetic of oxygen partial pressure decline) of 
importance in this regard? 
2) Do TIAR/TIA-1 proteins have any effects on the abundance and 
activity of HIF1α and are these effects dependent on stress granules 
formation?  
3) Do TIAR/TIA-1 proteins have any effect on proliferation and 
angiogenesis? 
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3 Materials and Methods 
 
3.1 Cell Culture 
 
3.1.1 Culture of the human lung adenocarcinoma A549 cell line 
 
Human lung adenocarcinoma A549 cell line, which was used in part of the 
experiments, was purchased from American Type Culture Collection (ATCC). 
The culture of the the human lung adenocarcinoma A549 cell line was 
performed according to the protocol given by the American Type Culture 
Collection (ATCC). The cells frozen in 10 % dimethylsulfoxid (DMSO) in 
liquid nitrogen (approx. 5 x 106 cells/ml) were thawed rapidly at 37 °C and 
then added drop wise to 100 mm dish containing 10 ml of pre-warmed 
DMEM/F12 (DMEM : F-12 (1:1) 500 ml, -L-Glutamin, Gibco, Karlsruhe) (1:1) 
culture medium (supplemented with 10 % FCS (v/v) (fetal calf serum, heat 
inactivated for 30 min at 56 °C, sterile filtered, (PAA Laboratories GmbH, 
Pasching, Österreich), 1 % (v/v) Gentamycin/Penicillin G (lyophilized, sterile, 
Gibco, Karlsruhe), 1 % vitamins (MEM Vitamin solution, Gibco, Karlsruhe), 1 
% L-glutamine (Gibco, Karlsruhe), and 1 % non essential amino acids (MEM 
Non-Essential Amino Acids, Gibco, Karlsruhe). When the cells became 
confluent, they were detached with 5 ml 1x trypsin (Gibco, Karlsruhe) per 100 
mm plate (Greiner Bio-One, Germany) for approximate 2 min at 37 °C. The 
reaction was stopped by adding 1 ml of FCS which contains trypsin inhibitors. 
For continuous culture, about 1/4 of the medium containing A549 cells were 
transferred to a fresh plate and cultured at 37°C in a gas controlled incubator 
(IR 1500 Automatic CO2 Incubator, Flow Laboratories GmbH, Meckenheim) 
with water-saturated atmosphere containing 5% CO2 .
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A549 Medium (500ml) 
DME-M/F12      430 ml  86 % 
FCS       50 ml   10 % 
Penicillin/Streptomycin   5 ml   1 % 
Vitamins     5 ml  1 % 
Non-essentials Aminoacids  5 ml  1 % 
Glutamine     5 ml  1 % 
 
1 x Trypsin Volume (100ml) 
10 x Trypsin      10 ml  10 % 
HEPES (200 mM)     10 ml  10 % 
Isotonic NaCl (0.9 %)    80 ml  80 % 
 
 
3.1.2 Culture of human umbilical vein endothelial cells (HUVEC) 
 
The endothelial cells, kindly provided by Dr. K. Mayer (University of Giessen 
Lung Center (UGLC), Justus-Liebig-University of Giessen, Giessen, 
Germany), were isolated from human umbilical veins (Human Umbilical Veins 
Endothelial Cells). Briefly, cells obtained from collagenase digestion were 
washed, pooled, centrifuged for 10 min at 210g, and resuspended in fresh 
medium. Before splitting, cells were grown for 2 to 3 days on T 75 culture 
flasks (Greiner Bio-One, Germany) coated with gelatine in an atmosphere of 
95% O2 and 5% CO2. For the experiments HUVECs from passage 2 and 3 
were used. Cells were cultured in Endothelial Cell Growth Medium 
(containing 10ml FCS, 2ml ECGS/H, 0.1ng EGF/ml, 0.1ng bFGF, 0.1µg 
Hydrocortison/ml in 500ml of medium) supplemented with Supplement Mix C-
39215 (all from PromoCell GmbH, Heidelberg, Germany). 
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3.2 Hypoxia experiments 
 
3.2.1 Hypoxia inducing methods 
 
A hypoxic environment was prepared in a chamber equilibrated with a 
water-saturated gas mixture and set to 1% O2, 5% CO2 or to 0.1% O2, 5% 
CO2 (Innova CO-48, New Brunswick Scientific, Edison, NJ, USA). For 
generating a rapid oxygen decline, EC-Oxyrase® (Oxyrase Inc., Mansfield, 
Ohio, USA) an enzyme that consumes O2 was added to the cell culture 
medium according to the company recommendations at a dilution of 1:100 
together with sodium lactate (Sigma-Aldrich, St. Louis, MO, USA) at 
concentration of 20 mM. For measuring of the O2 partial pressure in the cell 
culture medium, the Licox Oxygen Monitoring System (Integra, New Jersey, 
USA) was employed.  
 
3.2.2 Validating hypoxia within the cells using HypoxiprobeTM-1 
 
For validating the hypoxia within the A549 cells, the HypoxiprobeTM-1 kit 
(HPI, Inc., Burlington, MA, USA) was employed. This kit consists of two 
principal components: pimonidazole hydrochloride, a small molecule hypoxia 
marker that selectively binds to oxygen starved cells and Hypoxyprobe™-1-
Mab1, a monoclonal antibody that was used to detect pimonidazole adducts 
using immunocytoflorescence. During the incubation of the A549 cells in 
hypoxic conditions, pimonidazole hydrochloride was added in a concentration 
of 200 µM in the cell culture medium of the cells. After the incubation time (3 
h for Oxyrase and 4 h for hypoxic gas incubator), the cells were fixed and 
immunostained according to the protocol described in the next section.  
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3.3 Immunocyto- and immunohisto-fluorescent analyses 
 
3.3.1 Antibodies 
 
Primary antibodies 
 
Antibody Company Dilution 
c-Myc, raised in rabbit AbCam, Cambridge USA 1:500 
HIF-1α raised in rabbit LifeSpan Biosciences, 
Seattle, WA, USA 
1:200 
lamin B, raised in goat Santa Cruz Biotechnology, 
Santa Cruz, CA, USA 
1:250 
TIA-1 raised in goat Santa Cruz Biotechnology, 
Santa Cruz, CA, USA 
1:200 
TIAR, raised in mouse BD Biosciences, San Jose, 
California USA 
1:200 
 
Fluorescencent labelled secondary antibodies 
 
Antibody Company Dilution 
donkey anti-goat-cy3 Chemicon, Temecula, CA, 
USA 
1:4000 
donkey anti-mouse-Alexa 488 Invitrogen, Carlsbad, CA 1:1000 
donkey anti-rabbit-Alexa 488 Invitrogen, Carlsbad, CA 1:1000 
goat anti-mouse-Alexa 555 Invitrogen, Carlsbad, CA 1:1000 
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3.3.2 Immunostaining protocol 
 
Immunocytofluorescence was performed with A549 or HUVEC. For this 
purpose 30000 cells were cultured per each chamber slide well (Lab-Tek 
Thermofisher Scientific, Denmark) and then treated as indicated.  
Immunohistofluorescence was performed from cryosections (5 µm) of 
subcutaneous A549 xenograft tumors frozen in liquid nitrogen. The 
cryosection were obtained using a Cryostat set for -20°C (Leica CM1850 UV-
Kryostat, Leica Microsysteme Vertrieb GmbH, Bensheim) equipped with a 
microtome blade (Mikrotom Messer, S-35, Feather, PFM Produkte für die 
Medizin AG, Köln). The cryosection were fixed on glass slides (Super Frost® 
Plus Objektträger, 25 x 75 x 1 mm, R. Langenbrinck, Labor- und 
Medizintechnik, Teningen) and stored in -20 °C. 
The cells or tissues were fixed in 4 % paraformaldehyde for 20 min and then 
washed 3-times with phosphate buffered saline containing 0.1 % BSA and 
0.2 % Triton X-100. The non-specific binding sites were blocked with the 
same buffer enriched with 10 % horse serum for 30 min. The primary 
antibody was added and incubated for 2 h. After washing, the secondary 
antibody was added and incubated for 1 h at room temperature. 
Counterstaining of the nuclei was performed by addition of 1 µM DAPI 
(Sigma- Aldrich Chemie GmbH, Munich, Germany) for 5 min. Images were 
recorded using a Leica DMLA Q550/W microscope (Leica Microsysteme 
Vertrieb GmbH, Bensheim, Germany) with Leica Q-Win standard software. 
 
3.4 Western-blot analysis 
3.4.1 Samples preparation 
 
The samples for Western-blot were prepared by plating 150000 cells on 6 
well-plates (Greiner Bio-One, Germany) and using 2 wells for each group. The 
cells were transfected with si-RNA and/or cultured under hypoxic conditions, 
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depending on the experiment design. Cells were lysed in Laemmli buffer and 
placed on ice. The samples were heated at 90 °C for 5 min and the protein 
concentration was measured according to the Pierce BCA protein assay. 
Afterwards the samples were mixed with β-mercaptoethanol and 
bromophenol blue, and then loaded in equal protein amounts onto a sodium 
dodecyl sulfate polyacrylamide gel.  
 
Laemmli 4X (100 ml)  
 
Tris-HCl pH 6.8 (250 mM)    3 g 
40 % (v/v) Glycerol    40 ml 
8 % (p/v) SDS     5 g 
H20      to 100 ml 
 
*Add 10 % ß-mercaptoethanol and 0.005% (p/v) Bromophenol Blue only after 
measuring the protein concentration and before use. 
 
3.4.2 BCA protein concentration assay 
 
The BCA protein assay kit (Thermo Scientific, Pierce Biotechnology, 
Rockford, IL, USA) was used for the measurement of the protein 
concentration. This method is based on peptide bonds mediated reduction of 
Cu2+ to Cu1+ that interacts with bicinchoninic acid (BCA) generating a purple-
colored product and it is useful for the measurement of protein 
concentrations in buffers containing various chemical agents including SDS. 
Thus, samples dissolved in 1x Laemmli buffer were directly applicable for the 
protein concentration measurement. Preparation of standards (differently 
diluted bovine serum albumin), incubation conditions, spectrophotometric 
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measurement and calculation of protein concentration were performed 
according to the company’s protocol. The absorbance of the purple color 
product was measured on a 96 well plate (Nunc, Roskilde, Denmark) at 
492nm with a spectrofluorometer (FL-600, BioTek Instruments GmbH, Bad 
Friedrichshall, Germany). As background, values of absorbance of relevant 
buffer(s) were used.  
 
3.4.3 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
The gel electrophoresis, i.e. sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE), was performed with self-made 10% 
polyacrylamid gel. Equal amount of protein (between 5 µg and 50 µg, 
depending on the analyzed protein) was loaded from each sample on the gel 
In SDS-PAGE the denatured polypeptides bind SDS and become negatively 
charged. The amount of bound SDS is always proportional to the molecular 
weight of the polypeptide and is independent of its size and charge, therefore 
the SDS-polypeptide complexes migrate through polyacrylamide gels in 
accordance with the molecular weight of the polypeptides. By using 
prestained SDS-PAGE protein marker, PageRuler (Fermentas Life Sciences, 
Burlington, Ontario, Canada), it is therefore possible to estimate the 
molecular weight of the polypeptide chains. The electrophoresis was 
performed with 100 V constant in electrophoresis chambers (Bio-Rad, 
Hercules, CA, USA) and the gel was run till the bromophenol blue reaches 
the bottom of the separating gel (for about 2 h). Then, the gel can be used for 
western-blot analysis. 
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Separating Buffer Final concentration 
Tris     1.125 M 
Saccharose    30 % 
pH     8.8 
 
Collecting Buffer Final concentration 
Tris     0.625 M 
pH     6.8 
 
1 x Running Buffer Final concentration 
Tris     25 mM 
Glycine    192 mM 
SDS     0.1 % 
 
3.4.4 Electro blotting of immobilized proteins 
 
The separated proteins on the SDS-polyacrylamide gel were electrically 
transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore 
Corporation, Billerica, MA, USA) by semi dry electro blotting. The PVDF 
membrane was activated by methanol before use. The transfer equipment 
was prepared in the following way: two layers of blotting paper (Bio-Rad, 
Hercules, CA, USA) soaked with transfer buffer followed by activated PVDF 
membrane washed with transfer buffer were placed onto the electro-blotting 
chamber (Bio-Rad, Hercules, CA, USA). On the PVDF membrane, the gel 
and the other two layers of blotting paper soaked with transfer buffer were 
placed. The cathode and anode from the power supply were connected with 
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the electro-blotting chamber. Electro blotting was performed at constant 
current (2 mA/cm2) for 90 min. 
 
Transfer Buffer Final concentration 
Tris     25 mM 
Glycine    192 mM 
Methanol    20 % 
SDS     0.01 % 
 
3.4.5 Immunological detection of immobilized proteins 
 
Antibodies used in the experiments are all commercially available: 
 
Primary antibodies 
 
Antibody Company Dilution 
HIF-1α, raised in mouse  BD Biosciences / California, USA 1:3000 
TIA-1 raised in goat Santa Cruz Biotechnology, Santa 
Cruz, CA, USA 
1:500 
TIAR, raised in mouse BD Biosciences, San Jose, 
California USA 
1:1000 
β-actin, raised in mouse  Abcam, Cambridge, UK 1:10000 
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HRP-conjugated secondary antibodies 
 
Antibody Company Dilution 
Donkey Anti-goat IgG Thermo scientific, Pierce, 
Rockford, IL, USA 
1:2000 
Goat anti-mouse IgG Thermo scientific, Pierce, 
Rockford, IL, USA 
1:2000 
Goat anti-rabbit IgG Thermo scientific, Pierce, 
Rockford, IL, USA 
1:2000 
 
 
 
The membrane was blocked with 1 x NET buffer containing 0.25% skin 
porcine gelatin (Sigma-Aldrich, St. Louis, MO, USA) at room temperature 
(RT) for 2 h followed by incubation with primary antibody overnight at 4 °C. 
Then, the membrane was washed and incubated with horse radish 
peroxidase-conjugated secondary antibodies for 2 h. Immunoreactive signals 
were detected by ECL Plus Western Blot Detection System (GE Healthcare, 
AmershamTM, Buckinghamshire, UK) employing an imager system 
(FluorchemTM IS-8900, Alpha Innotech, San Leandro, CA, USA).  
 
Blocking Buffer Final concentration 
NaCl     150 mM 
EDTA (pH = 8.0)  5 mM 
Tris     50 mM 
Triton X-100    0.05 % 
Gelatine   0.25 % 
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10 x NET buffer Final concentration 
NaCl     1.5 M 
EDTA (pH = 8.0)   50 mM 
Tris     500 mM 
Triton X-100    0.5 % 
 
3.5 Small interfering RNA 
 
Selective targeting of TIAR and TIA-1 was performed using specific small 
interfering RNAs (siRNAs). As a control, a siRNA sequence (si-con) that 
does not target any gene in the human genome and has been tested by 
micro-array analysis (Dharmacon Inc., Chicago, IL, USA) was employed. The 
siRNAs were synthesized commercially (Biomers.net GmbH, Ulm, Germany).  
The sequences were as follows:  
 
si-con 
Forward 5′-UAGCGACUAAACACAUCAA dTdT-3′ 
Reverse 5′- UUGAUGUGUUUAGUCGCUA dTdT -3′ 
 
si-TIAR 
Forward 5′- GGGCUAUUCAUUUGUCAGA dTdT -3′ 
Reverse 5′- UCUGACAAAUGAAUAGCCC dTdT -3′ 
 
si-TIA-1 
Forward 5′- CGAUUUGGGAGGUAGUGAA dTdT -3′ 
Reverse 5′- UUCACUACCUCCCAAAUCG dTdT -3′ 
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3.6 Transfection of A549 and HUVEC cells 
 
The liposome mediated transfection method was employed for transfection of 
A549 cells. Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) transfection 
reagent was used for transfection of plasmid or si-RNA or both in A549 and 
HUVEC cells. One day before transfection, appropriate numbers of A549 or 
HUVEC cells was plated on respective culture dishes (all from Greiner Bio-
One, Germany) with culture medium so that they will become 90-95 % 
confluent for plasmid and 60 % confluent for si-RNA transfection at the time 
of transfection. DNA and/or si-RNA was diluted in Opti-MEM® reduced 
serum medium and mixed gently. Lipofectamine 2000 was mixed gently 
before use and then diluted in the appropriate amount of Opti-MEM® 
medium. Mixtures were mixed gently and incubated for 5 min at room 
temperature. After 5 min incubation, the diluted DNA and/or si-RNA and the 
diluted Lipofectamine 2000 were mixed and incubated for 20 min at room 
temperature to allow the DNA-Lipofectamine 2000 complexes to form. DNA-
lipofectamine complexes were added to each well containing cells and 
medium and mixed gently by rocking the plate back and forth. Cells were 
incubated in CO2 incubator at 37 °C for 5 h and the medium was replaced. 
Cells were further incubated either in normoxic or hypoxic incubator 
according to the experiment need. 
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Protocol for transfection of  A549 or HUVEC cells 
Method Culture 
vessel 
Seeding 
cell 
number 
Total 
volume 
per well 
(µl) 
Plasmid 
DNA 
(µg) 
Si-RNA 
(µl from 
40nmol 
stock) 
DNA/ 
RNA 
dilution 
volume 
(µl) 
Lipid 
dilution 
volume 
(µl) 
Western-Blot 6-wells 
plate 
150000 2500 - 2.5 250 250 
Cell-count 
assay 
24-wells 
plate 
5000 500 - 0.5 50 50 
Reporter 
gene assay or 
immunocyto-
fluorescence 
48-wells 
plate or 
chamber
-slides 
30000 250 0.3 0.25 25 25 
BrdU 
incorporation 
assay 
96-wells 
plates 
1000 150 - 0.15 25 25 
 
 
3.7 Reporter gene assay 
 
3.7.1 Recombinant plasmids  
 
The pGL3-TK plasmid (Promega) with the thymidine kinase minimal promoter 
was used to construct the HRE-plasmid employing the NheI and XhoI 
restriction sites. For cloning, forward and reverse oligonucleotides 
corresponding to the HRE from the phosphoglycerate kinase (PGK) gene 
(66) was used after annealing and restriction digest with NheI and XhoI: 
HRE-PGK: CTA GCG CGT CGT GCA GGA CGT GAC AAA TAG CGC GTC 
GTG CAG GAC GTG ACA AAT AGC GCG TCG TGC AGG ACG TGA CA 
AAT. Finally, a construct with five repeats of HRE-PGK ligated to the 5′ end 
of the TK-mp promoter were isolated and verified by sequencing. The 
pGL4.13 plasmid (Promega) was used for construction of the AUR plasmid. 
A synthetic sequence of the HIF-1α 3′ end with the putative AUR elements 
(CTA GGT ATT TAA ACC ATT GCA TTG CAG TAG CAT CAT TTT AAA 
AAA TGC ACC TTT TTA TTT ATT TAT TTT TGG CT) was used to ligate this 
sequence into the XbaI site located at the 3′ end of the firefly luciferase gene. 
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Transfection of A549 cells by plasmids was performed employing 
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). 
 
3.7.2 Experiment design and measurement of the Luciferase activity 
 
For the reporter gene assay 30000 A549 cells were plated on 48-wells plates 
(Greiner Bio-One, Germany) and transfected with plasmid (HRE or AUR-
luciferase reporter plasmid) and si-RNA. After 24h, the experiment was 
stopped (AUR experiments) or the cells were cultured for 4 h under hypoxic 
condition and then stopped (HRE experiments). 
The detection of luciferase activity in the cells transfected with reporter 
vectors containing the firefly luciferase gene was performed with the 
luciferase reporter assay kit (Promega, Mannheim, Germany). The luciferase 
assay is based on the enzyme-catalyzed chemiluminescence. Luciferin 
present in the luciferase assay reagent is oxidized by luciferase in the 
presence of ATP, air oxygen and magnesium ions. This reaction produces 
light with a wavelength of 562 nm that can be measured by a luminometer. 
After washing once with 1 x PBS, the transfected cells were shaken for 15 
min in 100 µl of 1 x lysis buffer, then frozen in -80 °C overnight and thawed at 
room temperature next day for measurement. For measurement of firefly 
luciferase activity, 20 µl of the lysate were mixed in white and flat bottom 96 
well plates with 100 µl luciferase assay reagent, which was freshly prepared 
by mixing substrate and the luciferase assay buffer.  
The activity of luciferase in cells transfected with AUR- and HRE-reporter 
plasmids was measured as relative light units (RLU) with the Luciferase 
Assay System (Promega Corporation, Madison, WI, USA) employing a 
Spectrofluorometer (FL-600 BioTek Instruments GmbH). 
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5 x lysis buffer (pH 7.8) Volume Final concentration 
1 M Tris    25 ml   125 mM 
200 mM EDTA   10 ml   10 mM 
500 mM DTT   4 ml   10 mM 
85 % Glycerol   115 ml  50 % 
Triton X-100    10 ml   5 % 
H2O    to 200 ml 
 
3.8 Cell count assay 
Cell proliferation was measured by cell count assay. This method consists in 
counting the cells from distinct groups treated differently. On the first day 
5000 A549 cells were plated on 24 wells plates (Greiner Bio-One, Nürtingen), 
each group consisting on 3 wells. On the second day the cells were 
transfected with si-RNA according to the si-RNA transfection protocol. For 
each time-point was prepared a 24 well plate consisting of all the analyzed 
groups. The considered time-points were 1 day, 2 days, 4 days and 6 days. 
At the specified time-point the cells from each well from the respective plate 
were detached using trypsine and counted.  
 
3.9 BrdU incorporation assay 
 
Cell proliferation was also measured by BrdU incorporation assay (Roche, 
Mannheim, Germany). This method is based on the incorporation of the 
pyrimidine analogue 5-bromo-2’-deoxyuridine (BrdU) instead of thymidine 
into the DNA of proliferating cells. After it’s incorporation into DNA, BrdU is 
detected by colorimetric immunoassay. One day before experiment, A549 
cells were plated in 96 well plates (1000 cells/well). On the second day, 
transfection of si-RNA was performed as described above and medium was 
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replaced by DMEM low-serum medium containing antibiotics (0.1 % (v/v) 
FCS, 1 % (v/v) penicillin and streptomycin) and incubated overnight for 
cellular synchronization. On the third day, the cells were cultured with normal 
culture medium. On the forth day was performed the BrdU incorporation (final 
con. 10 µM) for 4 h. After labeling with BrdU, the cells were fixed with 
FixDenat (200 µl/well) for 30 min at RT, and then the FixDenat solution was 
removed thoroughly by tapping and washed once with 1 x PBS before 100 µl 
of anti-BrdU-POD working solution was added to each well for 1 h. 
Afterwards, the anti-BrdU-POD solution was removed and each well rinsed 
three times with 300 µl of washing solution, 100 µl of peroxidase substrate 
(tetramethyl benzidine, TMB) was added for 5 min at RT, then 25 µl of 1M 
H2SO4 was added to each well and incubated for approximately 1 min on the 
shaker to stop the substrate reaction. The absorbance of the samples was 
measured at 450 nm excitation and 690 nm emission by spectrophotometer 
(FL-600, BIO-TEK Instruments, Inc., USA). The values given in the figures 
represent the raw data subtract blank control obtained by photometric 
measurement at 450 nm excitation and 690 nm emission. 
 
 
3.10 Tube formation assay 
 
Tube formation assay was employed for assessing the angiogenesis in vivo. 
For this purpose there were employed HUVEC, which were transfected with 
si-RNA, according to the protocol, 24 h before the experiment. On the day of 
the experiment, 250 µl liquid BD Matrigel™ (BD Biosciences, Canada) was 
pipetted on each well from a 24 well-plate (Greiner Bio-One, Nürtingen) and 
let for 30 min in a 37 °C incubator to solidify. Afterwards 60000 HUVEC were 
plated on each BD Matrigel™ containg well in 350 µl HUVEC medium. The 
cells were incubated at 37 °C for 16 h. Afterwards the wells were carefully 
washed with Hank’s buffered salt solution (HBSS) and then 300 µl Calcein 
AM (Fluka, BioChemika) in a dilution of 8 µg/ml was added on each well and 
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incubated for 30 min at 37 °C. The wells were again washed with HBSS and 
then pictures could be taken using the fluorescent filter and the 4x 
magnification of the microscope (Olympus Mikroskop, Gerätetyp JMT-2, 
Inverses Forschungsmikroskop, Olympus Deutschland GmbH, Hamburg). 
 
Hank's Stock Solutions 
 
Stock 1 
Dissolve the following in 90ml of distilled H2O  
8.0 g NaCl 
0.4 g KCl 
qs to 100 ml with distilled H2O 
 
Stock 2 
Dissolve the following in 90ml of distilled H2O  
0.358 g Na2HPO4 (anhydrous) 
0.60 g KH2PO4 
qs to 100 ml with distilled H2O 
 
Stock 3 
Add 0.72 g CaCl2 to 50ml of distilled H2O  
 
Stock 4 
Add 1.23 g MgSO4x7H2O to 50ml of distilled H2O  
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Stock 5 
Add 0.35 g NaHCO3 to 10ml of distilled H2O 
 
Hank's Premix 
 
Combine the solutions in following in order: 
10.0 ml Solution 1 
1.0 ml Solution 2 
1.0 ml Solution 3 
86.0 ml distilled H2O 
1.0 ml Solution 4 
 
Hank's full strength (mix prior to use) 
9.9 ml Hank's Premix 
0.1 ml Stock 5 
 
Hank's (Full Strength with carbonate) composition 
0.137 M NaCl 
5.4 mM KCl 
0.25 mM Na2HPO4 
0.44 mM KH2PO4 
1.3 mM CaCl2 
1.0 mM MgSO4 
4.2 mM NaHCO3 
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3.3 Statistical analysis 
 
All the data in the figures and text are expressed as means ± SEM of n 
independent observations unless indicated otherwise. Statistical evaluation 
was performed by unpaired t-test. 
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4 Results 
 
4.1 Formation of TIAR/TIA-1 containing stress granules under different 
stress conditions in A549 cells 
 
The formation of stress granules has been described in various mammalian 
cells. In this study, we aimed to analyze the hypoxic conditions regarding 
stress granule formation in A549 cells.  
As comparison, we employed stress conditions that were previously shown to 
induce the formation of stress granules such as heat-shock (67, 68) or H2O2 
(69). For this purpose, A549 cells were treated with 200 µM H2O2 for 3 h or 
cultured under elevated temperature (41 °C for 30 min) and then compared 
to control cells. Furthermore, the cytostatic drug imatinib (10 µM for 2 h), an 
agent that has not yet been investigated in this regard, was employed for the 
analysis of stress granule formation. When performing immunocyto-
fluorescent analysis for TIAR and TIA-1, stress granules were detected after 
treatments with H2O2, heat shock and imatinib. Stress granules were not 
detectable in untreated control cells (Figure 4).  
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Figure 4. Formation of TIAR/TIA-1 containing stress granules under different 
stress conditions in A549 cells. 
Immunocyto-fluorescent analysis of TIAR (green), TIA-1 (red) and the nuclear stain 
DAPI (blue) in A549 cells untreated (control), treated with H2O2 200 µm for 3 h, 
cultured under 41 °C for 30 min or treated with imatinib 10 µM for 2 h (scale bar 
represents 50 µm). 
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4.2 Analyses of different hypoxic conditions employed for culturing of 
A549 cells 
 
We investigated TIAR/TIA-1-dependent stress granule formation under 
different hypoxic conditions in cultured A549 cells compared to normoxic 
conditions. For this purpose, cells were placed within an incubator that was 
set to an oxygen concentration of either 1 % O2 or 0.1 % O2. Furthermore, we 
employed oxyrase, an enzyme that consumes oxygen from the medium thus 
generating low oxygen tensions in the medium. Employing these three 
different approaches, the oxygen concentrations within the cell supernatants 
were determined as a function of time. The settings of 1 % O2 and 0.1 % O2 
resulted in a final level of hypoxia of about 7 mmHg and 0.7 mmHg O2 partial 
pressure that was achieved after about 60 min. Employing oxyrase, a final O2 
partial pressure of about 7 mmHg was achieved. It is obvious from the 
displayed curves that the oxygen partial pressure decline was considerable 
stronger in case of the addition of oxyrase when compared to the settings of 
the incubator to either 1 % O2 or 0.1 % O2 (Figure 5). 
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Figure 5. Measurement of the oxygen partial pressure equilibration time in the 
cell supernatant.  
Measurement of the oxygen partial pressure equilibration time in the cell 
supernatant after setting the hypoxic incubator to 1 % O2, 0.1 % O2 or after addition 
of the enzyme oxyrase (see also text in the Results section). An incubator setting of 
1 % O2 resulted in an O2-partial pressure of about 7 mmHg, while an incubator 
setting of 0.1 % resulted in about 0.7 mmHg. The addition of oxyrase caused the 
strongest decline in O2-partial pressure, which reached about 7 mmHg. 
 
 
Furthermore, hypoxia within the A549 cells was validated by employing 
immunocyto-fluorescence analysis with HypoxiprobeTM-1 (pimonidazole 
hydrochloride), a well established hypoxia marker for cells or tissues (70, 71). 
The cells cultured under the mentioned hypoxic conditions were positive for 
the HypoxiprobeTM-1 staining while those cultured under normoxic conditions 
were negative for the HypoxiprobeTM-1 staining (Figure 6). 
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Figure 6. Validation of hypoxia in A549 cells cultured under different hypoxic 
conditions.  
Immunocyto-fluorescent analysis of HypoxiprobeTM-1 (green), a hypoxia marker and 
the nuclear stain DAPI (blue) in A549 cells cultured under normoxia, in a hypoxic 
incubator set for 1 % O2 and respectively 0.1 % O2 for 4 h or after addition of the 
enzyme oxyrase in the cell-culture medium for 3 h. Hypoxia (green) within the A549 
cells was observed under all 3 hypoxic condition and not under normoxia. 
 
 
4.3 Formation of TIAR/TIA-1 containing stress granules under different 
conditions of hypoxia in A549 cells 
 
To analyse the stress granule formation under hypoxic conditions, 
immunocyto-fluorescence analysis for TIAR and TIA-1 was performed in 
A549 cells cultured under normoxic or hypoxic conditions. 
Stress granules were detected under conditions of the addition of oxyrase or 
an incubator setting of 0.1 % O2 whereas stress granules were not detected 
at the setting of 1 % O2 or in normoxia. The stress granules were observed in 
about 10 % of the cells under oxyrase and about 20 % of the cells under 0.1 
% O2. Thus, the absolute hypoxic degree and the gradient of the oxygen 
decline contribute to the formation of stress granules in hypoxia. The 
occurrence of stress granules was transient and disappeared when re-
culturing the cells under normoxic conditions (Figure 7). 
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Figure 7. Formation of TIAR/TIA-1 containing stress granules under different 
conditions of hypoxia in A549 cells.  
Immunocyto-fluorescent analysis of TIAR (green), TIA-1 (red) and nuclear stain 
DAPI (blue) in A549 cells cultured under normoxia, in a hypoxic incubator set to 1 % 
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O2 or to 0.1 % O2 for 4 h, after addition of the enzyme oxyrase in the cell-culture 
medium for 3 h and additionally 3 h after removing the oxyrase-containing medium. 
Setting of the incubator to 0.1 % O2 and addition of oxyrase triggered the 
aggregation of TIAR/TIA-1 to stress granules whereas in normoxia and a setting of 
the incubator to 1 % O2 did not cause the formation of stress granules. The 
occurrence of stress granules was transient and disappeared when removing the 
oxyrase-containing medium and re-culturing the cells under normoxic conditions 
(scale bar represents 50 µm). 
 
 
4.4 Immunocyto-fluorescent analysis of HIF-1α, c-Myc and lamin B in 
relation to TIAR and the nuclear stain DAPI in A549 cells cultured 
in hypoxia. 
 
Since HIF-1α is an important factor that is induced in hypoxia, we further 
analyzed how TIAR/TIA-1 dependent stress granules affect the accumulation 
of HIF-1α. Immunocyto-fluorescent costaining of HIF-1α and TIAR in A549 
cells cultured under hypoxia 0.1 % O2 revealed that cells displaying stress 
granule were negative for HIF-1α whereas HIF-1α was expressed in the 
nucleus of cells without stress granules. In comparison, we also analyzed the 
transcription factor c-Myc an established target of TIAR (39, 72) and the 
nuclear protein lamin-b used as a non-target control. Accordingly, c-Myc 
expression was abolished in cells with stress granules but not in cells without 
stress granules whereas lamin-b expression was not affected by stress 
granules (Figure 8). 
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Figure 8. Immunocyto-fluorescent analysis of HIF-1α, c-Myc and lamin B in 
relation to TIAR and the nuclear stain DAPI in A549 cells cultured in hypoxia.  
In cells displaying stress granules (labelled with a white circle) expression of HIF-1α 
is abrogated. Also, the expression of c-Myc an established target of TIAR is 
abrogated in cells with stress granules whereas expression of lamin B expression is 
not affected in cells with stress granules. Arrows indicate some cells without stress 
granules. In these cells HIF-1α and c-Myc are expressed (scale bar represents 50 
µm). 
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4.5 Inhibition of TIAR and TIA-1 by siRNA (si-TIAR, si-TIA-1) in relation 
to a random siRNA (si-con) in A549 cells 
For further analysis of the dependence of HIF-1 on TIAR and TIA-1, selective 
inhibition of TIAR and TIA-1 was performed using specific siRNAs (si-TIAR, 
si-TIA-1). As a control, was employed a siRNA sequence (si-con) that does 
not target any gene in the human genome and has been tested by micro-
array analysis. After 48 h after transfection, the inhibitory effects of the 
selected siRNA sequences were validated by Western-blot analysis in 
relation to the loading control β-actin and by immunocytologic-fluorescent 
analysis in relation to DAPI staining (Figure 9 A and B). Both methods 
showed that si-TIAR and si-TIA-1 were reducing the level of the targeted 
protein, respectively. Of note is an upregulation of TIA-1 in cells treated with 
si-TIAR. 
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Figure 9. Inhibition of TIAR and TIA-1 by siRNA (si-TIAR, si-TIA-1) in relation to 
a random siRNA (si-con) in A549 cells.  
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Validation of the inhibitory effects of si-TIAR and si-TIA-1 treatment in comparison to 
si-con on TIAR and TIA-1 as measured by A) Western-blot analysis in relation to the 
loading control β-actin and by B) immunocytologic-fluorescent analysis in relation to 
DAPI staining. Of note is that the inhibition of TIAR caused an increase of TIA-1 
(scale bar represents 100 µm). 
 
 
4.6 Effects of TIAR and TIA-1 on HIF-1α 
 
A549 cells were transfected with si-TIAR, si-TIA-1 or with si-con employed as 
a control. 48 h later, the cells were incubated under normoxia or hypoxia 
(4h). The Western-blot analysis revealed the typical induction of HIF-1α 
under hypoxia which was enhanced in the cells transfected with si-TIAR of si-
TIA-1 when compared to the si-con group. ß-actin was used as a loading 
control (Figure 10).  
 
 
Figure 10. Effects of the treatment of A549 cells by si-TIAR or si-TIA-1 
compared to si-con on the expression of HIF-1α analysed by Western-blot.  
Western-blot analysis shows the typical increase of HIF-1α in hypoxia and a further 
increase of HIF-1α after treatment of cells by si-TIAR or si-TIA-1. β-actin was used 
as a loading control. 
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Similar results were obtained by immunocyto-fluorescent analysis. The 
experiments were conducted in a similar manner. Cells were transfected with 
si-TIAR, si-TIA-1 or si-con and after 48 h cells were cultured under normoxic 
or hypoxic conditions. Co-staining of HIF-1α and TIA-1 Figure 11 A or of HIF-
1α and TIAR Figure 11 B was performed afterwards. The nuclei were stained 
with DAPI (blue). As expected, the normoxic cells displayed no HIF-1α 
signal. The hypoxic cells revealed the typical HIF-1α induction and the cells 
treated by si-TIAR and si-TIA-1 displayed strong enhancement of HIF-1 α 
signal in hypoxia in comparison with the cells treated with si-con.  
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Figure 11. Effects of the treatment of A549 cells by si-TIAR or si-TIA-1 
compared to si-con on the expression of HIF-1α, analysed by 
immunocytologic-fluorescence.  
A) Immunocytologic-fluorescent analysis of HIF-1α (green), TIA-1 (red) and nuclear 
stain DAPI (blue) in A549 cells transfected with si-TIAR, si TIA-1 or si-con. HIF-1α 
was enhanced after treatment of cells by si-TIAR or by si-TIA-1 in cells not 
displaying any stress granules. B) Immunocytologic-fluorescent analysis of HIF-1α 
(green), TIAR (red) and nuclear stain DAPI (blue) in A549 cells transfected with si-
TIAR, si TIA-1 or si-con. HIF-1α was enhanced after treatment of cells by si-TIAR or 
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by si-TIA-1 in cells not displaying any stress granules (scale bar represents 
100 µm). 
 
 
4.6.1 HRE reporter gene assay 
 
Furthermore an HRE reporter gene assay was employed to analyse the 
effects of TIAR/TIA-1 on HIF-1α dependent target gene expression. The 
A549 cells were cotransfected with the HRE-plasmid and concomitantly with 
si-TIAR, si-TIA-1 or si-con. In hypoxia, the expected activation of luciferase 
activity was noticed. Treatment of cells by si-TIAR or si-TIA-1 resulted in 
enhanced activation of luciferase activity when compared to si-con further 
supporting that TIAR/TIA-1 inhibits HIF-1-dependent target gene expression 
(Figure 12). This effect was more pronounced in cells treated with si-TIAR 
than in cells treated with si-TIA-1. Of note is that this effect was also obvious 
under normoxic conditions. 
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Figure 12. HRE-reporter gene analyse of A549 cells treated by si-TIAR or si-
TIA-1 compared to si-con.  
Diagram of the HRE-reporter plasmid employed for the experiment as shown below. 
Treatment by si-TIAR and si-TIA-1 causes an upregulation of HRE-dependent 
luciferase activity in normoxia and hypoxia compared to si-con. (n=3, SEM, p<0.05, 
unpaired t-test). 
 
 
4.6.2 AUR reporter gene assay 
 
TIAR and TIA-1 were demonstrated to mediate their specific effects to target 
mRNAs by AU-rich elements (AUR) located at the untranslated 3’end of the 
mRNAs. A possible AUR-sequence within the 3’ end of the HIF-1α mRNA 
was identified by in silico screening. Coupling of this putative AUR-element to 
a luciferase reporter gene plasmid resulted in significant downregulation of 
luciferase expression in transfected A549 cells compared to cells transfected 
with the control plasmid (consider the si-con bars) (Figure 13). Concomitant 
si-TIAR transfection resulted in upregulation of luciferase expression in cells 
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transfected with the AUR-plasmid but not in cells transfected with the control 
plasmid when compared to si-con. Concomitant si-TIA-1 transfection caused 
downregulation of luciferase activity in cells transfected with the control-
plasmid but a slight upregulation in cells transfected with the AUR-plasmid 
when compared to si-con. These experiments reveal that TIAR and TIA-1 
downregulate the luciferase activity by targeting the AUR element. 
 
 
plasmid AUR-plasmid
0
5000
10000
15000
20000
si-con
si-TIAR*
*
s-TIA-1
*
*
R
LU
 
 
Figure 13. AUR-reporter gene analyse of A549 cells treated by si-TIAR or si-
TIA-1 compared to si-con.  
Diagram of the AUR-plasmid and control plasmid employed for the experiments 
shown below. Ligation of the AUR-sequence to the reporter plasmid results in 
downregulation of the luciferase activity. Concomitant treatment of cells by si-TIAR 
and si-TIA-1 leads to upregulation of luciferase activity only in cells transfected with 
the AUR containing plasmid (n=3, SEM, p<0.05, unpaired t-test). 
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4.7 HIF-1α and TIA-1 distribution in A549 tumor xenografts 
 
The distribution of HIF-1α and TIA-1 in vivo was analysed by 
immunohistologic-fluorescence in sections from A549 tumor xenografts. The 
first observation was that the distribution of HIF-1α and TIA-1 was not 
uniform throughout the tumor section, most likely reflecting different 
oxygenation conditions within the tumor section (Figure 14). In addition, a 
nearly complementary pattern of HIF-1α and TIA-1 signals was observed 
reflecting the inhibitory effect of TIA-1 on HIF-1α as demonstrated in the cell 
culture studies employing si-TIAR and si-TIA-1. 
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Figure 14. Immunohistologic-fluorescent analysis of HIF-1α (green), TIA-1 
(red) and the merged version (HIF-1α + TIA-1) in sections from A549 tumor 
xenografts in relation to DAPI staining.  
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Of note is a nearly complementary expression pattern of HIF-1α and TIA-1 (scale 
bar represents 100 µm). 
 
 
4.8 Effects of TIAR and TIA-1 on proliferation 
 
TIAR and TIA-1 proteins have been described to target various mRNAs with 
quite different functions. In order to analyze the effects of TIAR and TIA-1 on 
proliferation, A549 cells were transfected with si-TIAR, si-TIA-1 or si-con and 
the proliferation was analysed employing two different methods.  
The first method used was cell count analysis. The A549 cells were plated in 
24-well plates and transfected as indicated. The cells were detached by 
trypsin treatment and counted at different time points: 1 day, 2 days, 4 days 
and 6 days after plating. An increase in cell count was observed in the A549 
cells transfected with si-TIAR and si-TIA-1 when compared to si-con and this 
effect was stronger in the si-TIAR group (Figure 15 A). 
The second method used was the BrdU incorporation assay for direct 
measurement of S-phase. For this purpose A549 cells were transfected with 
si-RNA as indicated and the BrdU incorporation was analysed after 4 days of 
transfection using a commercially available ELISA-Kit. This assay gave 
similar results as the cell count analysis, showing a stronger BrdU uptake in 
the cells transfected with si-TIAR or si-TIA-1 when compared to si-con. 
Employing this assay, no significant difference between the si-TIAR and si-
TIA-1 groups (Figure 15 B) was observed.  
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Figure 15. Effects of the treatment of A549 cells by si-TIAR or si-TIA-1 
compared to si-con on proliferation 
A) Cell count assay showing an increase in the number of the cells/well in the 
groups treated with si-TIAR or si-TIA-1 when compared to the si-con group. This 
effect was more pronounced in cells treated with si-TIAR than in cells treated with si-
TIA-1 (n=3, SEM, p<0.05, unpaired t-test). B) BrdU incorporation assay revealing an 
increase in BrdU incorporation in A549 cells treated with si-TIAR or si-TIA-1 when 
compared to the si-con group. (n=3, SEM, p<0.05, unpaired t-test). 
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4.9 Formation of TIAR/TIA-1 containing stress granules under different 
conditions of hypoxia in HUVEC cells 
 
Beside proliferation, angiogenesis plays an important role in tumor 
progression, a process that is strongly activated by HIF-1 in hypoxia. Since 
TIAR/TIA-1 has an inhibitory effect on HIF, we were interested to study the 
functional effects of TIAR/TIA-1 on angiogenesis employing endothelial cells.    
Initially, we analyzed whether stress granule formation is also observed 
under certain hypoxic conditions in HUVEC cells by immunocyto-fluorescent 
analysis for TIAR and TIA-1. HUVEC cells were cultured under normoxic 
conditions, in a hypoxic gas incubator set to 1 % O2 for 4 h or within a 
medium to which the enzyme Oxyrase was added for 3 h.  
Stress granules were detected under conditions of the addition of oxyrase, 
whereas stress granules were not detected at the setting of 1 % O2 or in 
normoxia. The stress granules were observed in about 10 % of the cells 
under oxyrase. The occurrence of stress granules was transient and 
disappeared after removing the oxyrase containing medium and culturing the 
cells under normoxic conditions for further 3 h (Figure 16). 
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Figure 16. Formation of TIAR/TIA-1 containing stress granules under different 
conditions of hypoxia in HUVEC cells.  
Immunocyto-fluorescent analysis of TIAR (green), TIA-1 (red) and nuclear stain 
DAPI (blue) in HUVEC cells cultured in normoxia, in a hypoxic incubator set to 1 % 
O2 for 4 h, and after addition of the enzyme oxyrase in the cell-culture medium for 3 
h and 3 h after removing the oxyrase-containing medium. The addition of oxyrase 
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triggered the aggregation of TIAR/TIA-1 to stress granules whereas normoxia and a 
setting of the incubator to 1 % O2 did not cause the formation of stress granules. 
The occurrence of stress granules was transient and disappeared when removing 
the oxyrase-containing medium and re-culturing the cells under normoxic conditions 
(bar represents 50 µm). 
 
 
4.10 Inhibition of TIAR and TIA-1 by siRNA in HUVEC cells 
 
For analysis of the dependence of angiogenesis on TIAR and TIA-1, 
selective silencing of TIAR and TIA-1 was performed in HUVEC cells. 48 h 
after transfection, the inhibitory effects of the selected siRNA sequences 
were validated by Western-blot analysis in relation to the loading control β-
actin (Figure 17). The results showed that si-TIAR and si-TIA-1 were 
reducing the level of the targeted protein. Of note is an upregulation of TIA-1 
in cells treated with si-TIAR. 
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Figure 17. Inhibition of TIAR and TIA-1 by siRNA (si-TIAR, si-TIA-1) in relation 
to a random siRNA (si-con) in HUVEC cells as measured by Western-blot.  
Validation of the inhibitory effects of si-TIAR and si-TIA-1 treatment in comparison to 
si-con on TIAR and TIA-1 as measured by Western-blot analysis in relation to the 
loading control β-actin. 
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4.11 Effects si-TIAR and si-TIA-1 on angiogenesis in endothelial cells 
 
For analysing the effects of TIAR/TIA-1 on angiogenesis, tube formation 
assay was performed. For this purpose HUVEC cells transfected with si-
TIAR, si-TIA-1 or si-con were cultured on Matrigel for 16 h and the total tube 
length formed within this time interval was measured. The total tube length is 
taken as an indicator of the angiogenetic potential of the HUVEC cells. 
Treatment by si-TIAR and si-TIA-1 caused an increase in the total numbers 
of tubes when compared to si-con (Figure 18).  
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Figure 18. Effects of the treatment of HUVEC cells by si-TIAR or si-TIA-1 
compared to si-con on angiogenesis as measured by tube formation assay. 
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Tube formation assay of HUVEC cells transfected with si-TIAR, si TIA-1 compared 
to si-con. Treatment by si-TIAR and si-TIA-1 causes an increase in the total tube 
length formed by HUVEC cultured on the Matrigel when compared to si-con (n=3, 
SEM, p<0.05, unpaired t-test) (scale bar represents 1000 µm). 
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5 Discussion 
 
 
Different mechanisms exist which regulate global and specific translation 
under conditions of hypoxia (31, 32). In this regard, the mRNA-binding 
proteins TIAR and TIA-1 are suggested to regulate the turnover and stability 
of specific mRNA targets, thereby affecting translational efficiency (50) with 
possible impact on gene regulation mediated by HIF-1.   
In this study, the formation of TIAR/TIA-1-containing stress granules was 
analyzed under different oxygen tensions. We observed that the absolute 
level of hypoxia (O2 ~ 0.7 mmHg) and the degree of oxygen decline (∆O2 > 
-10 mmHg/min) contributed to the formation of stress granules. Under these 
conditions, up to 20% of the cells developed stress granules, a ratio that 
would likely increase under even more severe hypoxic conditions and a more 
rapid oxygen decline. Formation of stress granules is triggered by the 
phosphorylation of the eukaryotic initiation factor eIF2α,  as was 
demonstrated in a study where stress granules were induced by heat shock 
or arsenite employing eIF2α mutants (67). Also, phosphorylation of eIF2α is 
triggered by hypoxia in a reversible manner (42, 43). Interestingly, the 
kinetics of eIF2α phosphorylation strongly depends on the severity of 
hypoxia. This is in accordance with our observation that the formation of 
stress granules strongly depends on the degree of and kinetics of the drop in 
O2 partial pressure. However, other triggers of stress granule formation such 
as agents that target eIF4A have been described as well and may contribute 
(73).  
The second important observation made in this study was that TIAR/TIA-1 
proteins strongly affect HIF-1 signaling. HIF-1α is a transcription factor that is 
specifically induced by limiting oxygen concentrations (15). HIF-1α 
expression was blocked in cells bearing TIAR/TIA-1 containing stress 
granules. This effect was comparable with the inhibition of expression of the 
c-Myc transcription factor, a known target of TIAR (39, 72), whereas 
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expression of the non-target nuclear protein lamin B was unaffected. We 
employed specific inhibition of TIAR and TIA-1 by RNA interference to 
analyze effects of TIAR and TIA-1 exerted on HIF-1α. Of note is that TIAR 
inhibition caused an upregulation of expression of TIA-1. In other studies, 
TIA-1 overexpression led to a drop in TIAR levels also revealing dependence 
between TIAR and TIA-1 expression (58, 74). Based on their structural 
similarity, as well as from genetic knockout models, it is suggested that TIAR 
and TIA-1 are redundant to some extent and can compensate for each other. 
Inhibition of TIAR and TIA-1 also upregulated HIF-1α expression in cells 
without TIAR/TIA-1 containing stress granules, as demonstrated by 
immunocytochemical and western blot experiments with TIAR, TIA-1 and 
HIF-1α. Inhibition of TIAR and TIA-1 also caused upregulation of HIF-1 target 
gene expression, as analyzed by HRE reporter gene assay. Inhibition of 
TIAR caused a stronger induction of HIF-1α than did inhibition of TIA-1. Both 
TIAR and TIA-1 are suggested to mediate their specific effects on mRNAs by 
sequences of the ARE type that are located at the 3′ untranslated mRNA 
end. TIAR- and TIA-1-specific target mRNAs, as well as common targets of 
both, have been described (39, 40, 53, 54, 58, 75). These target mRNAs are 
suggested to share similar motifs however, a unique consensus sequence 
could not be identified.  
A putative AUR sequence from the HIF-1α mRNA sequence was identified 
by an in silico search employed for the cloning experiments. This sequence 
was characterized by three AUUUA motifs, and thus represents the class I 
AUR-type that is defined by the occurrence of up to five copies of this motif 
(76). The class I type motif is the most common type observed in the mRNA 
sequences of transcription factors. Coupling of this sequence to a reporter 
gene diminished its expression. A functional link between this AUR-sequence 
and TIAR/TIA-1 mediated effects on HIF-1α was supported by the 
observation that inhibition of TIAR and to a lesser extent inhibition of TIA-1 
attenuated the AUR-dependent downregulation of the expression the coupled 
reporter gene. In this regard, one study revealed significant binding of TIAR 
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to HIF-1α mRNA that was not induced in hypoxia whereas binding of TIA-1 
was almost not detectable (77). First, these observations may reflect our 
finding that the inducible effects exerted on HRE- reporter gene activity were 
much stronger pronounced after si-TIAR than after si-TIA-1 treatment. 
Second, in particular the effects of TIAR on HIF-1a could be observed both in 
normoxia and hypoxia at a different absolute level but with a similar ratio 
(Figure 13). 
The complete blockade of HIF-1α by TIAR/TIA-1-containing stress granules 
under conditions of extreme hypoxia or by a rapid drop in cellular 
oxygenation represents an important level of HIF-1α regulation. Triggering of 
the HIF pathway can result in the induction of about 100 target genes. This 
process itself consumes ATP (because of de novo transcription and 
translation), but requires some time to become effective. Particularly in the 
short term, ATP generation is optimized by shifting from mitochondrial 
respiration towards glycolysis. In the long term, cellular oxygenation is 
improved by induction of erythropoiesis and angiogenesis. In the case of 
rapid oxygenation decline and low absolute oxygen concentrations, triggering 
of the HIF pathway may exceed the actual ATP supply. Thus, transient 
blockage of the HIF-1 pathway may be of benefit for the cell. Stress granules 
silence mRNAs encoding HIF-1α and enable rapid and enhanced 
engagement of the hypoxic gene regulatory program in stages when 
reoxygenation occurs that cause the depolymerization of stress granules.  
This phenomenon was suggested to be relevant in the context of the 
development of radioresistance in tumors (62, 78). Irradiation caused 
reoxygenation of tumors that was accompanied by the depolymerization of 
TIAR-dependent stress granules. In turn, HIF-1 signaling was enhanced 
leading to augmented translation and secretion of angiogenic factors that 
enhanced the viability of endothelial cells in the tumor vasculature.  
Furthermore, this study analyzed the functional role of TIAR/TIA-1 in cell 
proliferation and angiogenesis. Inhibition of TIAR and TIA-1 by siRNA led to 
the stimulation of proliferation in A549 cancer cells and angiogenesis in 
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HUVEC endothelial cells. This might be caused by enhancement of the 
translation of TIAR/TIA-1 dependent target mRNAs (39, 79) including those 
of HIF1α. that affect proliferation and angiogenesis (16, 80). Also, blockage 
of the pro-apoptotic effects of TIAR/TIA-1 may contribute to enhanced 
proliferation (56, 57). One recent study investigated the effects of TIAR/TIA-1 
on global gene expression by DNA-microarray. In this study, an increase of a 
gene cluster encoding inflammatory, angiogenic and cell growth related 
genes was observed after silencing of TIAR/TIA-1 employing Hela cells. In 
these cells silencing of TIAR/TIA-1 also caused an increase of proliferation 
and anchorage independent growth (81). 
 
In conclusion, we demonstrated that TIAR/TIA-dependent stress granule 
formation depends on the degree of hypoxia and the kinetic of oxygen partial 
pressure decline. Furthermore, we identified HIF-1α as a functional target of 
TIAR/TIA-1 mRNA binding proteins, likely mediated by AUR sequences of 
HIF-1α mRNA. In particular, TIAR/TIA-1 inhibited HIF-1α expression most 
strongly under conditions when TIAR/TIA-1 containing stress granules 
occurred but also to a lesser extent under conditions where no stress 
granules are visible. Additionally TIAR/TIA-1 was demonstrated to have 
inhibitory effects on proliferation. Furthermore, TIAR/TIA-1 displayed 
inhibitory effects on angiogenesis being likely mediated by its inhibitory effect 
on HIF-1α.   
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6 Summary 
 
 
T-cell intracellular antigen (TIA)-1 and TIA-1 related protein (TIAR) are 
mRNA-binding proteins that aggregate within stress granules under specific 
stress conditions. In this study, we analyzed TIAR/TIA-1 aggregation under 
different hypoxic conditions, and studied the effects on hypoxia-inducible 
factor (HIF)-1α, as well as on proliferation and angiogenesis. TIAR/TIA-1 
formed stress granules under acute and pronounced hypoxic conditions in 
A549 adenocarcinoma cells. In parallel, HIF-1α expression was blocked in 
cells displaying TIAR/TIA-1 stress granules. Silencing of TIAR and TIA-1 
caused upregulation of HIF-1α expression, as demonstrated by western blot, 
immunocytochemistry, and HIF-1α-dependent reporter gene expression. 
TIAR/TIA-1 are suggested to mediate their effects by interaction with certain 
mRNA regions. Thus, a critical region of the 3′ end of the untranslated HIF-
1α cDNA with possible adenosine-uridine rich (AUR) elements was coupled 
to a reporter gene plasmid. Indeed, this coupling caused downregulation of 
the reporter gene expression, supporting the relevance of this mRNA region 
for the effects of TIAR/TIA-1 exerted on HIF-1α. Furthermore, employing this 
reporter construct inhibition of TIAR by siRNA attenuated the inhibitory cis-
effect of this AUR sequence. Additionally, immunohistochemical analysis of 
A549 cell tumor xenografts revealed a nearly complementary expression of 
HIF-1α and TIAR. This in vivo observation may reflect the inhibitory 
regulation of HIF-1α by TIAR as revealed in the cell culture studies. In sum, 
rapid and severe hypoxia caused TIAR/TIA-1-dependent formation of stress 
granules, specifically suppressing HIF-1α expression. Additionally TIAR/TIA-
1 was demonstrated to exhibit inhibitory effects on proliferation and 
angiogenesis.  
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7 Zusammenfassung 
 
 
T-cell intracellular antigen (TIA)-1 und TIA-1 related protein (TIAR) sind 
mRNA-bindende Proteine, welche unter bestimmten Stressbedingungen zu 
Stressgranula aggregieren. In dieser Arbeit wurde die Aggregation von 
TIAR/TIA-1 unter verschiedenen Hypoxie Bedingungen analysiert. Zudem 
wurde der Effekt auf den Hypoxie-induzierbaren Faktor (HIF-1α)  sowie auf 
Proliferation und Angiogenese in humanen Adenokarzinomzellen (A549) 
untersucht. 
TIAR/TIA-1 formten Stressgranula unter akuten und extremen 
Hypoxiebedingungen. In Zellen mit TIAR/TIA-1-haltigen Stressgranula war 
keine Expression von HIF-1α nachweisbar. Inhibition der Expression von 
TIAR und TIA-1 mit siRNA verursachte eine Hochregulation von HIF-1α. 
Diese wurde nachgewiesen durch Western Blot, Immunzytofluoreszenz und 
HIF-1α-abhängige Reportergen Expression. Die Effekte von TIAR/TIA-1 
werden vermutlich durch Interaktion mit bestimmten mRNA Sequenzen 
vermittelt. Daher wurde eine kritische Region des 3’-Endes der nicht 
translatierten HIF-1α cDNA mit möglichen Adenosin-Uridin reichen (AUR) 
Elementen an ein Reportergen Plasmid gekoppelt, was eine 
Herunterregulation der Expression des Reportergens bewirkte. Diese 
Beobachtung stützt die Relevanz dieser mRNA Sequenz für die 
beobachteten Effekte von TIAR/TIA-1 auf HIF-1α. Ferner führte die Inhibition 
von TIAR mit siRNA beim Einsatz dieses Reporterkonstruktes zur 
Abschwächung des inhibitorischen cis-Effektes der AUR-Sequenz. 
Interessanterweise zeigte in weiteren Experimenten, die Analyse von A549 
Xenotransplantaten durch Immunhistofluoreszenz eine nahezu 
komplementäre Expression von HIF-1α und TIAR an. Diese in vivo 
Beobachtung ist stimmig mit der inhibierenden Regulation von HIF-1α durch 
TIAR, wie sie in den Zellkulturstudien beobachtet wurde. 
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Zusammenfassend verursacht akute und extreme Hypoxie die TIAR/TIA-1-
abhängige Bildung von Stressgranula mit spezifischer Unterdrückung der 
HIF-1α Expression. Außerdem konnten für TIAR/TIA-1 inhibitorische Effekte 
auf Proliferation und Angiogenese nachgewiesen werden. 
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